Volume 5.26 | Jul 15

Pancreatic Cell News 5.26 July 15, 2014
Pancreatic Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Pancreatic Cell News on Twitter
 
TOP STORY
Identification of a New Class of MDM2 Inhibitor that Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
The authors performed a virtual screen and structure-based design to identify specific inhibitors of MDM2. They tested the activities of compounds identified on viability, proliferation, and protein levels of HPAC, Panc-1, AsPC-1, and Mia-Paca-2 pancreatic cancer cell lines. [Gastroenterology] Abstract
[Free On-Demand Webinar] Detect Cancer Stem Cells with ALDEFLUOR™ - Watch Now.
 
PUBLICATIONS (Ranked by impact factor of the journal)
DIABETES & PANCREATITIS

Regulation of Inflammatory Phenotype in Macrophages by a Diabetes-Induced Long Non-Coding RNA
Investigators used RNA-seq to profile the transcriptome of bone marrow macrophages isolated from diabetic db/db mice and identified 1648 differentially expressed genes compared to control db/+ mice. [Diabetes] Abstract

GABA Promotes Human β-Cell Proliferation and Modulates Glucose Homeostasis
γ-aminobutyric acid (GABA) exerts protective and regenerative effects on mouse islet β-cells. However, in humans it is unknown whether it can increase β-cell mass and improve glucose homeostasis. To address this question, investigators transplanted a suboptimal mass of human islets into immunodeficient NOD-scid-gamma mice with streptozotocin-induced diabetes. [Diabetes] Abstract

Evidence of Contribution of iPLA2β-Mediated Events During Islet β-Cell Apoptosis Due to Proinflammatory Cytokines Suggests a Role for iPLA2β in T1D Development
In view of reports of elevated Ca2+-independent phospholipase A2β (iPLA2β) in type 1 diabetes, investigators examined whether iPLA2β participates in cytokine-mediated islet β-cell apoptosis. [Endocrinology] Abstract

Possible Involvement of Toll-Like Receptor 7 in the Development of Type 1 Autoimmune Pancreatitis
The authors studied nine cases of type 1 autoimmune pancreatitis with ten cases of alcoholic chronic pancreatitis and three of the samples from non-tumorous lesion of neuroendocrine tumor as control subjects. They counted the number of Toll-like receptor-1 (TLR1)-11-positive cells immunohistochemically stained with anti-TLR1-11 antibodies. [J Gastroenterol] Abstract

Pancreatic Insulin-Producing Cells Differentiated from Human Embryonic Stem Cells Correct Hyperglycemia in SCID/NOD Mice, an Animal Model of Diabetes
Researchers generated pancreatic insulin-producing cells from two human embryonic stem cell lines, YT1 and YT2, using an optimized four-stage differentiation protocol in a chemically defined culture system. Then, about 5-7×106 differentiated cells were transplanted into the epididymal fat pad of SCID/NOD mice. [PLoS One]
Full Article

Aberrant Innate Immune Activation following Tissue Injury Impairs Pancreatic Regeneration
Investigators used a combination of genetically modified mice, immunological blockade and cellular characterization to identify the immune cells that impact pancreatic regeneration in an in vivo model of pancreatitis. [PLoS One] Full Article

Conversion of Human Pancreatic Acinar Cells toward a Ductal-Mesenchymal Phenotype and the Role of Transforming Growth Factor β and Activin Signaling
After seven days in monolayer culture, human acinar cells coexpressed the mesenchymal marker vimentin and the ductal marker Sox9. However, when the human exocrine cells were cultured in suspension, epithelial-mesenchymal transition was not observed. [Pancreas] Abstract

PANCREATIC CANCER

RIG-I-Like Helicases Induce Immunogenic Cell Death of Pancreatic Cancer Cells and Sensitize Tumors toward Killing by CD8+ T Cells
Scientists investigated immunogenic consequences of RIG-I-like helicases (RLH)-induced tumor cell death. Treatment of murine pancreatic cancer cell lines with RLH ligands induced production of type I IFN and proinflammatory cytokines. [Cell Death Differ] Abstract

Anticancer Activity of HS-527, a Novel Inhibitor Targeting PI3-Kinase in Human Pancreatic Cancer Cells
Scientists synthesized HS-527, a new PI3-kinase inhibitor, and investigated not only its anticancer activity, but also its mechanism of action in pancreatic cancer cells. [Cancer Lett] Abstract

MicroRNA-218 Inhibits Cell Invasion and Migration of Pancreatic Cancer via Regulating ROBO1
Researchers restored the expression of miRNA-218 in pancreatic cancer to clarify the function and potent downstream pathway of miRNA-218. The cell migration and invasion abilities were evaluated by migration assay and invasion assay respectively. [Cancer Biol Ther] Full Article

Request Sample: ReLeSR™, Easy Passaging Through Selective Detachment of hPSCs
 
REVIEWS
Recent Advances in the Regulation of Pancreatic Secretion
This review summarizes a number of recent studies demonstrating the intracellular pathways by which hormones and neural inputs regulate pancreatic exocrine and endocrine secretion. In particular, the effects of vasoactive intestinal peptide and secretin on intra-acinar cell adenosine 3′,5′-cyclic monophosphate are explored. [Curr Opin Gastroenterol] Abstract

Visit our reviews page to see a complete list of reviews in the pancreatic cell research field.
 
INDUSTRY NEWS
Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology for the Treatment of Diabetes
Sernova Corp. announced it has agreed on key terms with the University Health Network of Toronto (UHN) to gain access to worldwide, exclusive rights to certain patent-pending technologies developed by distinguished UHN researchers for the advancement of insulin-producing stem cells for the treatment of patients with insulin-dependent diabetes. [Sernova Corp. (Marketwire L.P.)] Press Release

Ethics Approval Granted for OncoSil™ Clinical Pivotal Trial in Pancreatic Cancer
OncoSil Medical Limited announced that it has been granted ethics approval for the Australian hospital sites for the pivotal clinical trial for its lead product candidate, the OncoSil™ localized radiation therapy treatment for pancreatic cancer. [OncoSil Medical Limited] Press Release

From our sponsor: Learn about assays for cord blood. Download the free technical bulletin.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 9th International Conference of Anticancer Research
October 6-10, 2014
Sithonia, Greece

Visit our events page to see a complete list of events in the pancreatic cell community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Research Assistant – Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy for Pancreatic Cancer Stem Cells (Queen Mary University of London)

Associate Director of Global Marketing – Pancreatic Cancer (Celgene Corporation)

Professorship – Molecular Mechanisms of Diabetes Pathogenesis (University of Southern Denmark)

Postdoctoral Fellow – Metabolism (University of Copenhagen)

PhD Scholarships – Diabetes (Danish Diabetes Academy)

Diabetes UK RD Lawrence Fellowships (Diabetes UK)

Postdoctoral Fellow – Mechanisms that Drive Gastrointestinal Malignancies (Washington University School of Medicine)

Postdoctoral Fellowship – Calcium Signaling (Brigham & Women’s Hospital – Harvard Medical School)

Postdoctoral Position – Role of Calreticulin in TGF-Beta Signaling in the Kidney Proximal Tubule under Diabetic Conditions (University of Alabama)

Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Pancreatic Cell News: Archives | Events | Contact Us